» Authors » Paul Devroey

Paul Devroey

Explore the profile of Paul Devroey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 184
Citations 3964
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Wathlet S, Adriaenssens T, Segers I, Verheyen G, Janssens R, Coucke W, et al.
Fertil Steril . 2012 May; 98(2):432-9.e1-4. PMID: 22633264
Objective: To relate the gene expression in cumulus cells surrounding an oocyte to the potential of the oocyte, as evaluated by the embryo morphology (days 3 and 5) and pregnancy...
22.
Bonduelle M, Mannaerts B, Leader A, Bergh C, Passier D, Devroey P
Hum Reprod . 2012 May; 27(7):2177-85. PMID: 22587997
Study Question: Is treatment with corifollitropin alfa, a new recombinant gonadotrophin with sustained follicle-stimulating activity, safe in terms of perinatal complications and birth defects in infants conceived following corifollitropin alfa...
23.
Polyzos N, Tournaye H, Devroey P
Hum Reprod . 2012 Apr; 27(6):1876-7. PMID: 22473393
No abstract available.
24.
Stoop D, Vercammen L, Polyzos N, De Vos M, Nekkebroeck J, Devroey P
Fertil Steril . 2012 Apr; 97(6):1328-30. PMID: 22464081
Objective: To assess whether there is an increased risk of infertility in women that have previously undergone ovarian stimulation and oocyte retrieval for oocyte donation. Design: Cross-sectional survey. Setting: Tertiary...
25.
Boostanfar R, Mannaerts B, Pang S, Fernandez-Sanchez M, Witjes H, Devroey P
Fertil Steril . 2012 Mar; 97(6):1351-8. PMID: 22459628
Objective: To compare live birth rates after fresh embryo transfer (ET) and cumulative ongoing pregnancy rates after fresh ET and frozen-thawed (ET) between continents and overall after one treatment cycle...
26.
Polyzos N, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, et al.
Reprod Biomed Online . 2012 Mar; 24(5):532-9. PMID: 22417669
Evidence regarding the role of anti-Müllerian hormone (AMH) among oocyte donors is limited and only involves gonadotrophin-releasing hormone (GnRH)-agonist-treated donors. This trial assessed the predictive ability of AMH for ovarian...
27.
Guzman L, Ortega-Hrepich C, Albuz F, Verheyen G, Devroey P, Smitz J, et al.
Fertil Steril . 2012 Feb; 98(2):503-7.e1-2. PMID: 22365339
Objective: To test the developmental competence of oocytes in a nonhCG-triggered in vitro maturation (IVM) system when oocyte-cumulus complexes (OCC) are retrieved from antral follicles with a diameter of <6...
28.
Blockeel C, Engels S, De Vos M, Haentjens P, Polyzos N, Stoop D, et al.
Reprod Biomed Online . 2012 Feb; 24(3):272-80. PMID: 22296973
This randomized controlled trial analyses the ability to control the oocyte retrieval schedule of gonadotrophin-releasing hormone antagonist cycles through the administration of oestradiol valerate during the luteo-follicular transition period prior...
29.
Devroey P, Pellicer A, Nyboe Andersen A, Arce J
Fertil Steril . 2012 Jan; 97(3):561-71. PMID: 22244781
Objective: To compare the efficacy and safety of highly purified menotropin (hphMG) and recombinant FSH (rFSH) for controlled ovarian stimulation in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Design:...
30.
Stoop D, De Munck N, Jansen E, Platteau P, Van den Abbeel E, Verheyen G, et al.
Reprod Biomed Online . 2012 Jan; 24(2):180-5. PMID: 22222248
Controversy exists about the risk of microbiological contamination from direct contact with unsterile liquid nitrogen during oocyte vitrification. The aim of this observational study was to evaluate the effectiveness of...